URGN
UroGen Pharma (URGN)
$80
About UroGen Pharma (URGN)
UroGen Pharma Ltd. is a biopharmaceutical company, which engages in developing and commercializing innovative solutions that treat urothelial and specialty cancers. It also focuses on developing RTGel reverse-thermal hydrogel, a proprietary sustained release and hydrogel-based platform technology. The company was founded by Asher Holzer in 2004 and is headquartered in Princeton, NJ.
Details
Daily high
$23.20
Daily low
$21.72
Price at open
$21.92
52 Week High
$30.00
52 Week Low
$3.42
Market cap
1.1B
Dividend yield
0.00%
Volume
540,817
Avg. volume
959,700
P/E ratio
-6.59
UroGen Pharma News
Details
Daily high
$23.20
Daily low
$21.72
Price at open
$21.92
52 Week High
$30.00
52 Week Low
$3.42
Market cap
1.1B
Dividend yield
0.00%
Volume
540,817
Avg. volume
959,700
P/E ratio
-6.59